Cargando…
Growth hormone-releasing hormone agonist attenuates vascular calcification in diabetic db/db mice
INTRODUCTION: Vascular calcification (VC) is an independent risk factor for cardiovascular diseases. VC increases mortality of all-causes. VC is one of most common cardiovascular complications in type II diabetes. So far, no therapy has been proven to be effective in treatment of clinical VC. The pr...
Autores principales: | Ren, Hao-Lin, Cai, Ruiping, Xue, Ruize, Zhang, Yaoxia, Xu, Qian, Zhang, Xianyang, Cai, RenZhi, Sha, Wei, Schally, Andrew V., Zhou, Ming-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889365/ https://www.ncbi.nlm.nih.gov/pubmed/36742073 http://dx.doi.org/10.3389/fcvm.2023.1102525 |
Ejemplares similares
-
Structural Motif Descriptors as a Way To Elucidate
the Agonistic or Antagonistic Activity of Growth Hormone–Releasing
Hormone Peptide Analogues
por: Jeanne Dit Fouque, Kevin, et al.
Publicado: (2018) -
Agonist of growth hormone-releasing hormone improves the disease features of spinal muscular atrophy mice
por: Boido, Marina, et al.
Publicado: (2023) -
Growth Hormone-Releasing Hormone in Lung Physiology and Pulmonary Disease
por: Zhang, Chongxu, et al.
Publicado: (2020) -
S-Propargyl-Cysteine Attenuates Diabetic Cardiomyopathy in db/db Mice Through Activation of Cardiac Insulin Receptor Signaling
por: Li, Ye, et al.
Publicado: (2021) -
Agonistic analogs of growth hormone releasing hormone (GHRH) promote wound healing by stimulating the proliferation and survival of human dermal fibroblasts through ERK and AKT pathways
por: Cui, Tengjiao, et al.
Publicado: (2016)